Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feiyang Yan

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Oncoimmunology|August 18, 2025
CAR-T cell engineered with TCR-like antibody specific for HBV surface antigen epitope E183-91/HLA-A *0201 exhibit potent activity against HBV-HCCFengling Wang, Jiaqian Li, Yong Huang, et al.
Cancer Letters|July 1, 2023
Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in miceJing Li, Weilin Zhou, Dan Li, et al.
Human Gene Therapy|November 2, 2023
Chimeric Antigen Receptor-T Cell Therapy Decreases Distant Metastasis and Inhibits Local Recurrence Post-surgery in MiceDan Li, Lin Jiang, Weilin Zhou, et al.
Molecular Cancer Therapeutics|March 19, 2025
CD24-targeted CAR-T cells mediated long-term anti-tumor efficacy through activation of endogenous tumor immune responsesYong Huang, Xiao Yang, Jing Li, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Oncoimmunology|August 18, 2025
CAR-T cell engineered with TCR-like antibody specific for HBV surface antigen epitope E183-91/HLA-A *0201 exhibit potent activity against HBV-HCCFengling Wang, Jiaqian Li, Yong Huang, et al.
Cancer Letters|July 1, 2023
Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in miceJing Li, Weilin Zhou, Dan Li, et al.
Human Gene Therapy|November 2, 2023
Chimeric Antigen Receptor-T Cell Therapy Decreases Distant Metastasis and Inhibits Local Recurrence Post-surgery in MiceDan Li, Lin Jiang, Weilin Zhou, et al.
Molecular Cancer Therapeutics|March 19, 2025
CD24-targeted CAR-T cells mediated long-term anti-tumor efficacy through activation of endogenous tumor immune responsesYong Huang, Xiao Yang, Jing Li, et al.
Pageof 2